Severin joined 3i in 2014 in the Frankfurt office and is a member of 3i's global Healthcare sector team.

He was a deal team member on 3i’s investments in ten23, xSuite, MAIT, Christ and Formel D. He was also involved in the investment in Evernex. As a core member of the deal team, he led the successful sale of ATESTEO.

Before joining 3i, Severin worked at UBS Investment Bank and was Business Development Manager for Auxilium, a portfolio company of HAL Investments, which is active in the sale of medical aids.

Severin graduated with a CEMS Master in International Management from the Rotterdam School of Management and HEC Paris.